Time to Abandon Renalism Patients with Kidney Diseases Deserve Morey

被引：3
作者：
Gaut, Joseph P. [1 ,2 ]
机构：
[1] Washington Univ, Dept Pathol & Immunol, Sch Med St Louis, St Louis, MO USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2023年 / 18卷 / 04期
关键词：
cancer; chronic kidney disease; policy;
D O I：
10.2215/CJN.0000000000000127
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：419 / 420
页数：2
相关论文
共 7 条
  • [1] Research Priorities for Kidney-Related Research-An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation
    Baliker, Mary
    Bansal, Nisha
    De Boer, Ian
    Bonventre, Joseph
    Breyer, Matthew
    Chapman, Arlene
    Crews, Deidra
    Ditschman, Erich
    Ferre, Silvia
    Flythe, Jennifer
    Fowler, Kevin
    Franceschini, Nora
    Freedman, Barry
    Friedman, Robert
    Harris, Peter C.
    He, John Cijiang
    Himmelfarb, Jonathan
    Humphreys, Benjamin D.
    Gutierrez, Orlando M.
    Ishibe, Shuta
    Ix, Joe
    Jefferson, Nichole
    Kestenbaum, Bryan
    Koyner, Jay
    Kramer, Holly
    McCowan, Precious
    Murray, Ryan
    Olabisi, Opeyemi
    Palevsky, Paul
    Parikh, Samir M.
    Pearce, Sharon
    Peti-Peterdi, Janos
    Quaggin, Susan E.
    Reed, Janine
    Roberts, Glenda V.
    Rohall-Andrade, Anne
    Rosas, Sylvia
    Sarnak, Mark
    Scialla, Julie J.
    Seliger, Steve
    Siew, Eddie
    Spencer, John David
    Susztak, Katalin
    Vassalotti, Joseph
    Willis, Kerry
    Young, Bessie A.
    Zimmerman, Troy
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (02) : 141 - 152
  • [2] Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development Landscape Analysis of Anticancer Agents Approved from 2015 to 2019
    Butrovich, Morgan A.
    Reaves, Allison C.
    Heyward, Jamie
    Moore, Thomas J.
    Alexander, G. Caleb
    Inker, Lesley A.
    Nolin, Thomas D.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (04): : 455 - 464
  • [3] Reduced Estimated GFR and Cancer Mortality
    Iff, Samuel
    Craig, Jonathan C.
    Turner, Robin
    Chapman, Jeremy R.
    Wang, Jie J.
    Mitchell, Paul
    Wong, Germaine
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (01) : 23 - 30
  • [4] Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management - The renal insufficiency and anticancer medications (IRMA) study
    Launay-Vacher, Vincent
    Oudard, Stphane
    Janus, Nicolas
    Gligorov, Joseph
    Pourrat, Xavier
    Rixe, Olivier
    Morere, Jean-Francois
    Beuzeboc, Philippe
    Deray, Gilbert
    [J]. CANCER, 2007, 110 (06) : 1376 - 1384
  • [5] Lichtman MA, 2017, J CLIN ONCOL, V35, P1376, DOI [10.1200/JCO.2016.70.4056, 10.1200/JCO.2017.74.4102]
  • [6] Onconephrology: The intersections between the kidney and cancer
    Rosner, Mitchell H.
    Jhaveri, Kenar D.
    McMahon, Blaithin A.
    Perazella, Mark A.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (01) : 47 - 77
  • [7] Improving Cancer Care for Patients With CKD : The Need for Changes in Clinical Trials
    Sprangers, Ben
    Perazella, Mark A.
    Lichtman, Stuart M.
    Rosner, Mitchell H.
    Jhaveri, Kenar D.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2022, 7 (09): : 1939 - 1950
1